AI protein design lessons from COVID-19 point to pandemic-ready vaccines
When SARS-CoV-2 first swept across the globe in early 2020, the pharmaceutical world faced a brutal mismatch: conventional vaccine and antibody discovery pipelines, built around sequential experimental screening and validation, typically need years to move from concept to clinic, while News…